FDAFDA · Food and drugs·Recall number D-0910-2016
LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL
Published June 8, 2016 · Recall initiated: March 31, 2016
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Manufacturer
- Invisiblu International LLC
- Distributor
- Nationwide and Brazil.
- Lot
- Lot # 21511166, Exp 11/18
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.